Position in AMGN
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$15,333,247
+$161,124 QoQ
Shares Held
42,343
-1.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
1.40%
of 13F equity value
Holder Rank
#432
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JACOBS & CO/CA holds $94,475,102 across 9 Drug Manufacturers - General names. AMGN ranks #3 (16.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,017 | $34,803,863 | |
| 2 | ABBV |
AbbVie Inc.
|
61,621 | $15,506,308 | |
| 3 | AMGN |
Amgen Inc
This page
|
42,343 | $15,333,247 | |
| 4 | MRK |
Merck & Co., Inc.
|
103,952 | $13,357,832 | |
| 5 | JNJ |
Johnson & Johnson
|
48,675 | $12,361,989 | |
| 6 | PFE |
Pfizer Inc
|
82,804 | $1,993,920 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,090 | $516,730 | |
| 8 | NVS |
Novartis AG
|
2,520 | $394,934 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,333,247 | 42,343 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $15,172,123 | 43,121 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $14,263,842 | 43,579 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $12,715,649 | 45,059 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $12,279,935 | 43,981 | Shares | Sole | 2025-07-02 | |
| 2025-03-31 | $13,682,964 | 43,919 | Shares | Sole | 2025-04-03 | |
| 2024-12-31 | $11,508,819 | 44,156 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $14,202,372 | 44,078 | Shares | Sole | 2024-10-01 | |
| 2024-06-30 | $14,025,880 | 44,890 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $12,866,332 | 45,253 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $13,034,057 | 45,254 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $12,361,078 | 45,993 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $10,409,851 | 46,887 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $11,159,421 | 46,161 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $12,100,350 | 46,072 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $10,546,691 | 46,791 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $11,384,736 | 46,793 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $11,526,592 | 47,666 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $10,680,225 | 47,474 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $9,786,578 | 46,022 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $9,983,512 | 40,958 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $9,679,704 | 38,904 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $8,877,671 | 38,612 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $9,762,031 | 38,409 | Shares | Sole | 2020-12-03 | |
| 2020-06-30 | $9,113,866 | 38,641 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $8,125,215 | 40,079 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||